Clinical significance of coronary arterial ectasia

doi:10.1016/0002-9149(76)90315-5

The American Journal of Cardiology

Volume 37, Issue 2, February 1976, Pages 217-222

https://doi.org/10.1016/0002-9149(76)90315-5 Get rights and content

Abstract

In a study group of 2,457 consecutive patients undergoing cardiac catheterization, 30 patients had coronary arterial ectasia, an irregular dilatation of major vessels up to seven times the diameter of branch vessels. The frequency of hypertension, abnormal electrocardiogram and history of myocardial infarction was greater than that in a control group with obstructive coronary artery disease. Patients with ectasia did not differ from patients with obstructive disease in sex, age, prevalence of angina or presence of metabolic abnormalities. Six deaths occurred in the group with ectasia during a mean follow-up period of 24 months (annual rate 15 percent). Extensive destruction of the musculoelastic elements was evident, resulting in marked attenuation of the vessel wall. The short-term prognosis in this group is the same as in medically treated patients with three vessel obstructive coronary artery disease.

References (17)

AS Daoud et al.
Aneurysms of the coronary artery
Am J Cardiol
(1963)
S Chaithiraphan et al.
Multiple aneurysms of coronary artery in sclerodermal heart disease
Angiology
(1973)
BRM Crook et al.
Mycotic aneurysms of coronary arteries
Br Heart J
(1973)
S Sayegh et al.
Multiple aneurysms of the coronary arteries
Am Heart J
(1968)
S Oram et al.
The heart in scleroderma
Br Heart J
(1961)
Diseases of the Heart and Blood Vessels, Nomenclature and Criteria for Diagnosis
(1964)
DS Frederickson et al.
Fat transport in lipoprotein—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
DS Frederickson et al.
Fat transport in lipoprotein—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
DS Frederickson et al.
Fat transport in lipoprotein—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
DS Frederickson et al.
Fat transport in lipoprotein—an integrated approach to mechanisms and disorders
N Engl J Med
(1967)
AVG Bruschke et al.
Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5–9 years. I. Arteriographic correlations
Circulation
(1973)

There are more references available in the full text version of this article.

Cited by (490)

Receptor for advanced glycation end products polymorphisms in coronary artery ectasia
2024, Gene
Although the implication of receptor of advanced glycation endproducts (RAGE) has been reported in coronary artery disease, its roles in coronary artery ectasia (CAE) have remained undetermined. Furthermore, the effect of RAGE polymorfisms were not well-defined in scope of soluble RAGE (sRAGE) levels. Thus, we aimed to investigate the influence of the functional polymorphisms of RAGE -374T > A (rs1800624) and G82S (rs2070600) in CAE development.
This prospective observational study was conducted in 2 groups selected of 2452 patients who underwent elective coronary angiography (CAG) for evaluation after positive noninvasive heart tests. Group-I included 98 patients with non-obstructive coronary artery disease and CAE, and Group-II (control) included 100 patients with normal coronary arteries. SNPs were genotyped by real-time PCR using Taqman® genotyping assay. Serum sRAGE and soluble lectin-like oxidized receptor-1 (sOLR1) were assayed by ELISA and serum lipids were measured enzymatically.
The frequencies of the RAGE -374A allele and -374AA genotype were significantly higher in CAE patients compared to controls (p < 0.001). sRAGE levels were not different between study groups, while sOLR1 levels were elevated in CAE (p = 0.004). In controls without systemic disease, -374A allele was associated with low sRAGE levels (p < 0.05), but this association was not significant in controls with HT. Similarly, sRAGE levels of CAE patients with both HT and T2DM were higher than those no systemic disease (p = 0.02). The -374A allele was also associated with younger patient age and higher platelet count in the CAE group in both total and subgroup analyses. In the correlation analyses, the -374A allele was also negatively correlated with age and positively correlated with Plt in all of these CAE groups. In the total CAE group, sRAGE levels also showed a positive correlation with age and a negative correlation with HDL-cholesterol levels. On the other hand, a negative correlation was observed between sRAGE and Plt in the total, hypertensive and no systemic disease control subgroups. Multivariate logistic regression analysis confirmed that the -374A allele (p < 0.001), hyperlipidemia (p < 0.05), and high sOLR1 level (p < 0.05) are risk factors for CAE. ROC curve analysis shows that RAGE -374A allele has AUC of 0.713 (sensitivity: 83.7 %, specificity: 59.0 %), which is higher than HLD (sensitivity: 59.2 %, specificity: 69.0 %), HT (sensitivity: 62.4 %, specificity: 61.1 %) and high sOLR1 level (≥0.67 ng/ml)) (sensitivity: 59.8 %, specificity: 58.5 %).
Beside the demonstration of the relationship between -374A allele and increased risk of CAE for the first time, our results indicate that antihypertensive and antidiabetic treatment in CAE patients causes an increase in sRAGE levels. The lack of an association between the expected -374A allele and low sRAGE levels in total CAE group was attributed to the high proportion of hypertensive patients and hence to antihypertensive treatment. Moreover, the RAGE -374A allele is associated with younger age at CAE and higher Plt, suggesting that -374A may also be associated with platelet activation, which plays a role in the pathogenesis of CAE. However, our data need to be confirmed in a large study for definitive conclusions.
Metabolomic analysis of serum from pure coronary artery ectasia patients based on UPLC-QE/MS technique
2022, Clinica Chimica Acta
Coronary artery ectasia (CAE) is a cardiovascular disorder characterized by abnormal coronary artery dilation and disturbed coronary flow. The exact pathophysiology of CAE is still unclear. We aimed to investigate differences in metabolomic profiles between CAE patients and healthy controls.
Radial artery blood samples were collected from 14 pure CAE patients, 12 mixed CAE patients with atherosclerosis, and 14 controls with normal angiography. Differential serum metabolites were analyzed by untargeted ultra-high performance liquid chromatography-mass spectrometry. Serum ICAM-1, VEGF, ROS, and glutathione levels were also measured.
Ten metabolites distinguished pure CAE patients from controls and mixed CAE, including 1-cyano-2-hydroxy-3-butene, 2,3-dihydro-6-methyl-5-(5-methyl-2-furanyl)-1H-pyrrolizine, 2-propionylpyrrole, 2-pyrrolidinone, 3-(2-furanylmethylene)pyrrolidine, D-alanine, furanofukinin, o-ethyltoluene, rotundine A, and SM(d18:1/18:1(9Z)). Related metabolic pathways include amino acid metabolism, sphingolipid dysfunction, energy metabolism, mitochondrial dysfunction, and oxidative stress. Serum concentrations of ICAM-1, VEGF and ROS were significantly elevated in CAE patients compared to controls, while glutathione decreased significantly in CAE patients. Moreover, ICAM-1 levels were negatively correlated with 2-propionylpyrrole, and VEGF levels were negatively correlated with SM(d18:1/18:1(9Z)), while GSH and ROS levels were correlated with the abundance of SM(d18:1/18:1(9Z)), further confirming systemic inflammation and oxidative stress in CAE.
This is the first report describing differential serum metabolomic profiles of pure CAE patients compared to mixed CAE and healthy controls, which revealed 10 potential biomarkers that can provide an early diagnosis of pure CAE. These discriminatory metabolites and related metabolic pathways can help to better understand the pathogenesis of pure CAE.
Prognostic role of coronary artery ectasia in patients with nonobstructive coronary artery disease
2024, Journal of Cardiovascular Medicine
Safety and efficacy results of percutaneous renal stent implantation in patients with acute coronary syndrome with ectatic and aneurysmatic coronary arteries
2024, Postgraduate Medicine
Differential Expression of Circulating Damage-Associated Molecular Patterns in Patients with Coronary Artery Ectasia
2024, Biomolecules
Isolated coronary artery ectasia presenting as inferior-posterior STEMI - A case-based state-of-the-art review of the current literature
2023, Romanian Journal of Cardiology / Revista Romana de Cardiologie

View all citing articles on Scopus

^☆: This study was supported by Grants HL-5679 and HL-11306 from the U. S. Public Health Service, Bethesda, Md.

View full text

Clinical studyClinical significance of coronary arterial ectasia☆

Abstract

Am J Cardiol

Angiology

Br Heart J

Am Heart J

Br Heart J

Diseases of the Heart and Blood Vessels, Nomenclature and Criteria for Diagnosis

Fat transport in lipoprotein—an integrated approach to mechanisms and disorders

N Engl J Med

Fat transport in lipoprotein—an integrated approach to mechanisms and disorders

N Engl J Med

Fat transport in lipoprotein—an integrated approach to mechanisms and disorders

N Engl J Med

Fat transport in lipoprotein—an integrated approach to mechanisms and disorders

N Engl J Med

Progress study of 590 consecutive nonsurgical cases of coronary disease followed 5–9 years. I. Arteriographic correlations

Circulation

Clinical study
Clinical significance of coronary arterial ectasia☆